C
Cellectar Biosciences D
D
CLRB
0.41230
USD
-0.02
(-4.78%)
قبل الجلسة
حجم التداول
1,945
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
18,998,732
الأخبار المقالات
العنوان: Cellectar Biosciences
القطاع: Healthcare
الصناعة: Biotechnology
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.